FCF Fox Company Finance GmbH is delighted to publish the brand new “FCF Biotech Enterprise Capital Monitor – USA 11/2021”. The Monitor is a month-to-month printed overview of enterprise...
An growing variety of medication of European origin have been in-licensed to Chinese language biotechnology corporations. During the last 5 years, a gradual improve within the variety of yearly...
FCF Fox Company Finance GmbH is delighted to publish the brand new “FCF Biotech Enterprise Capital Monitor – USA 10/2021”. The Monitor is a month-to-month printed overview of enterprise...
With a quantity of roughly USD 24bn, US biotech firms have already raised extra enterprise capital within the first three quarters of 2021 than in the entire 12 months...
FCF Fox Company Finance GmbH is delighted to publish the brand new “FCF Biotech Enterprise Capital Monitor – USA 09/2021”. The Monitor is a month-to-month printed overview of enterprise...
The financing quantity of European Biotech seed stage firms has considerably elevated in recent times. Since 2017, the funding quantity has elevated by roughly 200% to EUR 296m in...
FCF Fox Company Finance GmbH is delighted to publish the brand new “FCF Biotech Enterprise Capital Monitor – USA 08/2021”. The Monitor is a month-to-month printed overview of enterprise...
FCF Fox Company Finance GmbH is delighted to publish the brand new “FCF Biotech Enterprise Capital Monitor – USA 06/2021”. The Monitor is a month-to-month printed overview of enterprise...
After an astonishing improvement in Q1 2021 with a rise of 106% in comparison with Q1 2020, the gathered biotech enterprise capital funding quantity nonetheless exceeds the efficiency of...
September 23rd-24th 2021, Suzhou and On-line FCF co-organizes, along with its companion YAFO Capital, the ACCESS CHINA Biotech Discussion board – The most important China oriented healthcare partnering occasion....